Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tsukasa Nishioka is active.

Publication


Featured researches published by Tsukasa Nishioka.


Clinical Transplantation | 2003

Long‐term outcome of kidney transplant using non‐heart‐beating donor: multicenter analysis of factors affecting graft survival

Ryohei Hattori; Yoshinari Ono; Norio Yoshimura; Kiyotaka Hoshinaga; Tsukasa Nishioka; Michio Ishibashi; Shinichi Ohshima

Abstract: This multicenter study was retrospectively evaluated for the predictive factors affecting the long‐term graft survival of a kidney transplant from a non‐heart‐beating donor (NHBD).


International Journal of Urology | 2010

Carvedilol protects tubular epithelial cells from ischemia–reperfusion injury by inhibiting oxidative stress

Hayashi T; Marco A. De Velasco; Yoshitaka Saitou; Kazuhiro Nose; Tsukasa Nishioka; Tokumi Ishii; Hirotsugu Uemura

Objectives:  Renal ischemia–reperfusion injury (IRI), leading to acute kidney injury, is a frequent complication with renal transplantation and it is associated with graft function. Its pathogenesis involves ischemia, vascular congestion and reactive oxygen metabolites. Carvedilol is an antihypertensive drug with potent anti‐oxidant properties. In this study we investigated the protective effects of carvedilol in a rat renal IRI model.


Transplantation Proceedings | 2008

Efficacy of Carvedilol for Ischemia/Reperfusion-Induced Oxidative Renal Injury in Rats

Hayashi T; Yoshitaka Saitou; Kazuhiro Nose; Tsukasa Nishioka; Tokumi Ishii; Hirotsugu Uemura

In renal transplantation, ischemia/reperfusion (I/R) injury is related to production of reactive oxygen species. In addition to its antihypertensive action due to nonselective beta-adrenergic blocking activity, carvedilol has potent antioxidant activity. This study was designed to investigate the effects of carvedilol on I/R injury in rats. On postoperative days 2 and 4, serum creatinine levels were higher among the control and the metoprolol treatment groups compared with the carvedilol treatment group (P < .005). However, there were no significant differences on postoperative day 7. In conclusion, increased antioxidant modulation by carvedilol attenuated renal I/R injury.


Case Reports in Neurology | 2013

A Case of Severe Ganciclovir-Induced Encephalopathy

Hikaru Sakamoto; Makito Hirano; Kazuhiro Nose; Shuichi Ueno; Takashi Oki; Koichi Sugimoto; Tsukasa Nishioka; Susumu Kusunoki; Yusaku Nakamura

Background: Ganciclovir, a drug against cytomegalovirus (CMV) infection, is generally well tolerated, but can cause neurotoxicity such as encephalopathy. Although ganciclovir-induced encephalopathy has been described in several reports, a literature search revealed that ganciclovir concentrations in the blood or cerebrospinal fluid were previously measured in only 3 patients with encephalopathy. Symptoms usually include confusion and disturbed consciousness, which mimic CMV encephalitis. Prompt and accurate diagnosis is thus sometimes difficult, and is derived solely from accumulated clinical information of definite cases, since ganciclovir concentrations, not routinely measured, become available after several days or a few weeks. Case Presentation: Here, we summarize clinical information of all patients with definite ganciclovir-induced encephalopathy including our own patient, who had severe symptoms, with the highest reported trough concentration of ganciclovir in the blood, and underwent therapeutic dialysis with complete recovery. Conclusion: Our summary of patients with definite encephalopathy could lead to prompt and accurate diagnoses.


Transplantation Proceedings | 2008

Arterial stiffness after successful renal transplantation.

Tsukasa Nishioka; Takahiro Akiyama; Kazuhiro Nose; H. Koike

Cardiovascular disease is a major barrier to the long-term survival of transplant recipients. The aim of this study was to determine whether successful renal transplantation improves the arterial stiffness resulting from chronic renal failure. This study involved a group of 9 recipients (23-56 years) who underwent successful renal transplantation at our clinic. The brachial-ankle pulse wave velocity and--intima-media thickness of the bilateral common carotid arteries were measured in each patient before and 1 year after successful renal transplantation. One year after renal transplantation, the 9 patients showed a mean serum creatinine level of 1.41 mg/dL. Assessment of arterial stiffness in this group revealed that the mean brachial-ankle pulse wave velocity was reduced after renal transplantation, but there was no reduction in the mean intima-media thickness of the bilateral common carotid arteries. There was a significant correlation between the variance ratios of pulse wave velocity and median blood pressure. The more effective blood pressure control provided by renal transplantation may functionally improve arterial stiffness. However, organic arterial stiffness remained unchanged 1 year after transplantation.


Luts: Lower Urinary Tract Symptoms | 2013

Efficacy of Ramelteon in Patients with Insomnia and Nocturia.

Nobutaka Shimizu; Koichi Sugimoto; Masahiro Nozawa; Yasuyuki Kobayashi; Yutaka Yamamoto; Takafumi Minami; Hayashi T; Kazuhiro Yoshimura; Tokumi Ishii; Hirotsugu Uemura; Kazuhiro Nose; Tsukasa Nishioka

Objectives: To study the efficacy of ramelteon for patients with insomnia and nocturia.


Infection and Drug Resistance | 2013

Procalcitonin as a useful marker to decide upon intervention for urinary tract infection

Koichi Sugimoto; Nobutaka Shimizu; Naoki Matsumura; Takashi Oki; Kazuhiro Nose; Tsukasa Nishioka; Hirotsugu Uemura

Background Because the use of procalcitonin has been advocated as a marker of bacterial infection, this study was carried out to determine the usefulness of serum PCT as an early marker to decide upon intervention for urinary tract infection. Methods The subjects were 68 patients with urinary tract infection (UTI) in whom we measured serum procalcitonin concentration at the start of treatment. Results There were 47 patients with nonobstructed UTI and 21 with obstructed UTI. All patients with obstructed UTI were subjected to intervention. There were significant differences in procalcitonin, white blood cells, and creatinine levels between patients with nonobstructed and obstructed UTI (P < 0.05). Conclusion Although this retrospective study comprised a small number of patients, we found that procalcitonin was a useful marker to decide upon urinary intervention.


Research and Reports in Urology | 2015

A pilot study of acotiamide hydrochloride hydrate in patients with detrusor underactivity

Koichi Sugimoto; Takahiro Akiyama; Nobutaka Shimizu; Naoki Matsumura; Hayashi T; Tsukasa Nishioka; Hirotsugu Uemura

Aim To investigate the clinical efficacy of acotiamide hydrochloride hydrate in patients with detrusor underactivity. Methods We measured the post-void residual urinary volume in 19 patients with underactive bladders. All these patients had been under treatment with distigmine bromide and were prescribed acotiamide hydrochloride hydrate at a dose of 100 mg three times daily for 2 weeks. Results Compared with the post-void residual urinary volume value at baseline (161.4±90.0 mL) a statistically significant reduction was observed at the end of treatment (116.3±63.1 mL) (P=0.006). The drug was generally well tolerated by the majority of patients. Conclusion Maybe, acotiamide hydrochloride hydrate showed clinical efficacy in patients with underactive bladders and may, therefore, be used alternatively in patients who do not respond sufficiently to distigmine bromide.


Nature and Science of Sleep | 2013

Survey on lower urinary tract symptoms and sleep disorders in patients treated at urology departments

Nobutaka Shimizu; Yasuharu Nagai; Yutaka Yamamoto; Takafumi Minami; Hayashi T; Hidenori Tsuji; Masahiro Nozawa; Kazuhiro Yoshimura; Tokumi Ishii; Hirotsugu Uemura; Takashi Oki; Koichi Sugimoto; Kazuhiro Nose; Tsukasa Nishioka

Objectives This study examined the association between sleep disorders and lower urinary tract symptoms in patients who had visited urology departments. Methods This was an independent cross-sectional, observational study. Outpatients who had visited the urology departments at the Kinki University School of Medicine or the Sakai Hospital, Kinki University School of Medicine, between August 2011 and January 2012 were assessed using the Athens Insomnia Scale and the International Prostate Symptom Score. Results In total, 1174 patients (mean age, 65.7 ± 13.7 years), with 895 men (67.1 ± 13.2 years old) and 279 women (61.4 ± 14.6 years old), were included in the study. Approximately half of these patients were suspected of having a sleep disorder. With regard to the International Prostate Symptom Score subscores, a significant increase in the risk for suspected sleep disorders was observed among patients with a post-micturition symptom (the feeling of incomplete emptying) subscore of ≥1 (a 2.3-fold increase), a storage symptom (daytime frequency + urgency + nocturia) subscore of ≥5 (a 2.7-fold increase), a voiding symptom (intermittency + slow stream + hesitancy) subscore of ≥2 (a 2.6-fold increase), and a nocturia subscore of ≥2 (a 1.9-fold increase). Conclusion The results demonstrated that the risk factors for sleep disorders could also include voiding, post-micturition, and storage symptoms, in addition to nocturia.


Cancer management and research | 2013

Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery

Koichi Sugimoto; Nobutaka Shimizu; Takashi Oki; Kazuhiro Nose; Tsukasa Nishioka; Shogo Adomi; Takayuki Ohzeki; Atsunobu Esa; Hirotsugu Uemura

Background This study was undertaken to investigate the growth rate and clinical outcome of patients with a small renal mass (SRM) after delayed surgery. Methods We reviewed the clinical records of 34 patients with SRMs ≤ 4 cm at diagnosis, who underwent delayed surgical intervention during surveillance from January 2000 to December 2011. Radiographic evaluations using computed tomography (CT) scan and magnetic resonance imaging (MRI) were performed at least every 6 months, and the tumor size was determined at least twice. Results The mean follow-up time was 26.6 ± 18.6 months and mean tumor doubling time was 23.4 ± 16.0 months. Histopathological analysis revealed that 32 of the 34 patients were malignant in pT1aN0M0. Only one patient showed tumor recurrence, who subsequently died due to tumor progression. Conclusion The growth rate of the small renal mass was slow in the majority of our patients. Delayed intervention does not have a detrimental effect on cancer-specific outcomes.

Collaboration


Dive into the Tsukasa Nishioka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge